GB0919594D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0919594D0
GB0919594D0 GBGB0919594.2A GB0919594A GB0919594D0 GB 0919594 D0 GB0919594 D0 GB 0919594D0 GB 0919594 A GB0919594 A GB 0919594A GB 0919594 D0 GB0919594 D0 GB 0919594D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0919594.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0919594.2A priority Critical patent/GB0919594D0/en
Publication of GB0919594D0 publication Critical patent/GB0919594D0/en
Priority to PCT/EP2010/066962 priority patent/WO2011054947A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0919594.2A 2009-11-09 2009-11-09 Compounds Ceased GB0919594D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0919594.2A GB0919594D0 (en) 2009-11-09 2009-11-09 Compounds
PCT/EP2010/066962 WO2011054947A1 (en) 2009-11-09 2010-11-08 Thiadiazolidinedioxide p2x7 receptor antagonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0919594.2A GB0919594D0 (en) 2009-11-09 2009-11-09 Compounds

Publications (1)

Publication Number Publication Date
GB0919594D0 true GB0919594D0 (en) 2009-12-23

Family

ID=41502097

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0919594.2A Ceased GB0919594D0 (en) 2009-11-09 2009-11-09 Compounds

Country Status (2)

Country Link
GB (1) GB0919594D0 (en)
WO (1) WO2011054947A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2574840T3 (en) 2011-07-22 2016-06-22 Actelion Pharmaceuticals Ltd. Heterocyclic amide derivatives as antagonists of p2x7 receptors
NZ628910A (en) 2012-01-20 2016-02-26 Actelion Pharmaceuticals Ltd Heterocyclic amide derivatives as p2x7 receptor antagonists
ES2618056T3 (en) 2012-12-12 2017-06-20 Actelion Pharmaceuticals Ltd. Indole carboxamide derivatives as P2X7 receptor antagonists
AR094053A1 (en) 2012-12-18 2015-07-08 Actelion Pharmaceuticals Ltd DERIVATIVES OF INDOL CARBOXAMIDE AS ANTAGONISTS OF THE P2X RECEIVER
WO2014115078A1 (en) 2013-01-22 2014-07-31 Actelion Pharmaceuticals Ltd Heterocyclic amide derivatives as p2x7 receptor antagonists
ES2616114T3 (en) 2013-01-22 2017-06-09 Actelion Pharmaceuticals Ltd. Heterocyclic amide derivatives as P2X7 receptor antagonists
EP3962493A2 (en) 2019-05-03 2022-03-09 Flagship Pioneering Innovations V, Inc. Methods of modulating immune activity/level of irf or sting or of treating cancer, comprising the administration of a sting modulator and/or purinergic receptor modulator or postcellular signaling factor

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6133434A (en) 1997-04-28 2000-10-17 Glaxo Group Limited Purinergic receptor
SE0300445D0 (en) 2003-02-18 2003-02-18 Astrazeneca Ab New combination
US20070281931A1 (en) 2003-05-29 2007-12-06 Nigel Boughton-Smith Pharmaceutical Composition Containing a P2x7 Receptor Antagonist and Methotrexate
US20070010497A1 (en) 2003-05-29 2007-01-11 Nigel Boughton-Smith Pharmaceutical composition comprising a p2x7 antagonist and sulfasalazine
MXPA05012705A (en) 2003-05-29 2006-02-08 Astrazeneca Ab A pharmaceutical composition comprising a p2x7.
SE0302488D0 (en) 2003-09-18 2003-09-18 Astrazeneca Ab New combination
MXPA06014023A (en) 2004-06-29 2007-02-08 Warner Lambert Co Combination therapies utilizing benzamide inhibitors of the p2x7 receptor.
WO2006083214A1 (en) 2005-02-02 2006-08-10 Astrazeneca Ab Pharmaceutical composition comprising a p2x7 receptor antagonist and a hmg-coa reductase inhibitor
US20080207577A1 (en) 2005-07-11 2008-08-28 Astrazeneca Ab Combination I
WO2007008157A1 (en) 2005-07-11 2007-01-18 Astrazeneca Ab New combination 2
GB0724625D0 (en) * 2007-12-18 2008-01-30 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
WO2011054947A1 (en) 2011-05-12

Similar Documents

Publication Publication Date Title
GB0907425D0 (en) Compounds
EP2393493A4 (en) Compounds
GB0918249D0 (en) Compounds
EP2491025A4 (en) Azaazulene compounds
GB0907515D0 (en) Compounds
GB0914856D0 (en) Compounds
GB0915892D0 (en) Compounds
GB0919194D0 (en) Compounds
GB0905641D0 (en) Compounds
GB0909671D0 (en) Compounds
GB0919594D0 (en) Compounds
GB0915519D0 (en) Ntithrombotic compounds
GB0911000D0 (en) Compounds
EP2443115A4 (en) Compounds
GB0908941D0 (en) Compounds
GB0910675D0 (en) Compounds
GB0905060D0 (en) Compounds
GB0905932D0 (en) Compounds
GB0906433D0 (en) Compounds
GB0906853D0 (en) Compounds
GB0906854D0 (en) Compounds
GB0905057D0 (en) Compounds
GB0905054D0 (en) Compounds
GB0914594D0 (en) Compounds
GB0908942D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)